Advertisement for orthosearch.org.uk
Results 1 - 17 of 17
Results per page:
The Bone & Joint Journal
Vol. 106-B, Issue 5 | Pages 420 - 421
1 May 2024
Oussedik S Haddad FS


The Bone & Joint Journal
Vol. 106-B, Issue 2 | Pages 111 - 113
1 Feb 2024
Howard A Thomas GER Perry DC


The Bone & Joint Journal
Vol. 106-B, Issue 1 | Pages 3 - 5
1 Jan 2024
Fontalis A Haddad FS


The Bone & Joint Journal
Vol. 105-B, Issue 12 | Pages 1235 - 1238
1 Dec 2023
Kader DF Jones S Haddad FS


Bone & Joint Research
Vol. 12, Issue 10 | Pages 654 - 656
16 Oct 2023
Makaram NS Simpson AHRW

Cite this article: Bone Joint Res 2023;12(10):654–656.


The Bone & Joint Journal
Vol. 105-B, Issue 5 | Pages 467 - 470
1 May 2023
McBryde CW Prakash R Haddad FS


Bone & Joint Research
Vol. 11, Issue 8 | Pages 514 - 517
10 Aug 2022
Little CB Zaki S Blaker CL Clarke EC

Cite this article: Bone Joint Res 2022;11(8):514–517.


The Bone & Joint Journal
Vol. 104-B, Issue 5 | Pages 529 - 531
1 May 2022
Rajput V Haddad FS


The Bone & Joint Journal
Vol. 104-B, Issue 2 | Pages 189 - 192
1 Feb 2022
Scott CEH Clement ND Davis ET Haddad FS


The Bone & Joint Journal
Vol. 103-B, Issue 11 | Pages 1642 - 1645
1 Nov 2021
Kayani B Giebaly D Haddad FS


Bone & Joint Research
Vol. 10, Issue 9 | Pages 571 - 573
2 Sep 2021
Beverly MC Murray DW


Bone & Joint Research
Vol. 10, Issue 5 | Pages 307 - 309
3 May 2021
Eitner A Wildemann B


Bone & Joint Research
Vol. 10, Issue 2 | Pages 134 - 136
1 Feb 2021
Im G

The high prevalence of osteoarthritis (OA), as well as the current lack of disease-modifying drugs for OA, has provided a rationale for regenerative medicine as a possible treatment modality for OA treatment. In this editorial, the current status of regenerative medicine in OA including stem cells, exosomes, and genes is summarized along with the author’s perspectives. Despite a tremendous interest, so far there is very little evidence proving the efficacy of this modality for clinical application. As symptomatic relief is not sufficient to justify the high cost associated with regenerative medicine, definitive structural improvement that would last for years or decades and obviate or delay the need for joint arthroplasty is essential for regenerative medicine to retain a place among OA treatment methods. Cite this article: Bone Joint Res 2021;10(2):134–136


Bone & Joint Research
Vol. 9, Issue 10 | Pages 729 - 730
1 Oct 2020
Clarke SA


Bone & Joint Research
Vol. 8, Issue 10 | Pages 469 - 471
1 Oct 2019
Evans CH


Bone & Joint Research
Vol. 8, Issue 6 | Pages 224 - 225
1 Jun 2019
Wilkinson JM


Bone & Joint Research
Vol. 7, Issue 12 | Pages 636 - 638
1 Dec 2018
Roussot MA Haddad FS